● Resources ● Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis
Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis
Important notice regarding use of cookies: Our Privacy Policy reflects our use of cookies to collect and process data. By continuing to use this website, you agree to use our cookies and similar technologies as described in our Privacy Policy.